CVR number 33768389
Industry 86.2200 Specialist medical practice activities

SPECIALLÆGESELSKABET HUDKLINIKKEN NYKØBING F. ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 19.3% 6.8%  
Credit score (0-100)  0 0 0 9 37  
Credit rating  N/A N/A N/A B BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 399 272  
EBITDA  0.0 0.0 0.0 390 272  
EBIT  0.0 0.0 0.0 390 272  
Pre-tax profit (PTP)  0.0 0.0 0.0 370.0 288.6  
Net earnings  0.0 0.0 0.0 307.6 225.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 370 272  
 
See the entire income statement

Balance sheet (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 559 784  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 588 816  
Net Debt  0.0 0.0 0.0 -96.6 -516  
 
See the entire balance sheet

Volume 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 399 272  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -31.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 588 816  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 38.8%  
Added value  0.0 0.0 0.0 390.2 272.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 97.8% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 66.4% 38.8%  
ROI %  0.0% 0.0% 0.0% 69.8% 40.5%  
ROE %  0.0% 0.0% 0.0% 55.0% 33.5%  

Solidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Equity ratio %  0.0% 0.0% 0.0% 95.2% 96.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -24.8% -189.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Quick Ratio  0.0 0.0 0.0 20.7 26.0  
Current Ratio  0.0 0.0 0.0 20.7 26.0  
Cash and cash equivalent  0.0 0.0 0.0 96.6 515.7  

Capital use efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 559.2 420.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0